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Left ventricular hypertrophy (LVH) is the most common
cardiac abnormality in children with CKD. Experimental
and clinical studies demonstrated an association
between elevated serum levels of fibroblast growth fac-
tor 23 (FGF23) and LVH in CKD. The aim of our study
was to investigate i) the endogenous expression of
FGF23 in heart tissue of paediatric CKD patients, ii) to
establish the relationship between cardiac FGF23 expres-
sion and typical molecular mechanisms for LVH, and iii)
to evaluate whether cardiac FGF23 expression is asso-
ciated with LVH and other clinical parameters.
We conducted a retrospective case-control-study in 25
deceased paediatric patients (age 11±8y) with CKD stage
5 and 25 age and sex-matched healthy controls. Myocar-
dial autopsy samples of the left ventricle (LV) were eval-
uated by immunohistochemistry and qPCR with respect
to endogenous FGF23 expression, calcineurin-NFAT sig-
nalling, genes regulating cardiac remodelling, and brain
natriuretic peptide (BNP) as a marker of LVH.
Cardiac FGF23 expression increased in CKD patients
compared to controls (p<0.01), and correlated with LVH
demonstrated by enhanced BNP expression as well as
increased cardiomyocyte cross-sectional area (each
p<0.01). The calcineurin expression significantly
enhanced in cardiac tissue of CKD patients presenting
with LVH (p<0.05), and cardiac remodelling was con-
firmed by the enhanced expression of skeletal a-actin
and the significant reduction of cardiac a-actin com-
pared to controls (p<0.05). In the patient cohort, cardiac
FGF23 expression negatively correlated with the eGFR
(r=-0.526), and positively correlated with time-averaged
serum phosphate levels (r=0.503, each p<0.05). Likewise,
cardiac FGF23 expression was not increased in trans-
planted patients compared to controls.
For the first time, endogenous FGF23 expression was
detected in myocardial tissue. Cardiac FGF23 expression
as well as the FGF23 signalling pathway mediating car-
diac hypertrophy and hypertrophic gene programs were
induced in LVH positive CKD patients. We conclude
that, in extension to circulating FGF23 levels, both,
endogenous and circulating FGF23 contribute to LVH
in CKD.
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